S&R Biopharm

S&R Biopharm appears to be a Bulgaria-based life sciences company in Sofia focused on enabling regional access to CAR-T cell therapy. Publicly available evidence is limited, but the company was identified in 2020 as BiocurePharm Korea's Bulgarian partner for local manufacturing and commercialization of CD19 CAR-T products in Eastern Europe, including Bulgaria, Poland, and Turkey. Based on the available record, S&R Biopharm looks more like a commercialization and manufacturing partner than a fully disclosed drug-development company with a broad independent pipeline. There is not enough reliable public information to confirm a larger platform, financing history, or multiple proprietary clinical assets. The company therefore seems to be a niche cell-therapy-oriented biotech operating in the healthcare sector with sparse public disclosure.